Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 17;2(8):100375.
doi: 10.1016/j.xcrm.2021.100375. Epub 2021 Jul 27.

Combating information chaos: a case for collaborative clinical guidelines in a pandemic

Affiliations

Combating information chaos: a case for collaborative clinical guidelines in a pandemic

C Lee Cohen et al. Cell Rep Med. .

Abstract

The speed and scale of new information during the COVID-19 pandemic required a new approach toward developing best practices and evidence-based clinical guidance. To address this need, we produced COVIDProtocols.org, a collaborative, evidence-based, digital platform for the development and dissemination of COVID-19 clinical guidelines that has been used by over 500,000 people from 196 countries. We use a Collaborative Writing Application (CWA) to facilitate an expedited expert review process and a web platform that deploys content directly from the CWA to minimize any delays. Over 200 contributors have volunteered to create open creative-commons content that spans over 30 specialties and medical disciplines. Multiple local and national governments, hospitals, and clinics have used the site as a key resource for their own clinical guideline development. COVIDprotocols.org represents a model for efficiently launching open-access clinical guidelines during crisis situations to share expertise and combat misinformation.

Trial registration: ClinicalTrials.gov NCT04389671.

PubMed Disclaimer

Conflict of interest statement

Covidprotocols.org has been financially supported by USAID, USAID’s Sustaining Technical and Analytic Resources (STAR) project, and the John Doerr Family Foundation. The remaining authors have no disclosures or conflicts of interest relevant to this work. E.Y.K. is a co-investigator in NCT04389671 (Windtree Therapeutics) testing lucinactant (surfactant-like treatment) in COVID-19 patients. E.Y.K. has received unrelated research funding from Bayer, the U.S. National Institutes of Health, the American Heart Association, the American Lung Association, and the American Thoracic Society.

Figures

Figure 1
Figure 1
COVIDprotocols.org models a continuously updated collaborative clinical guideline process (A) Collaborative guidelines process; CWA, collaborative writing application (i.e., Google Docs). (B) COVIDprotocols.org homepage and key features.

References

    1. Gianola S., Jesus T.S., Bargeri S., Castellini G. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic. PLoS ONE. 2020;15:e0240123. - PMC - PubMed
    1. Kang M., Gurbani S.S., Kempker J.A. The Published Scientific Literature on COVID-19: An Analysis of PubMed Abstracts. J. Med. Syst. 2020;45:3. - PMC - PubMed
    1. Fraser N., Brierley L., Dey G., Polka J.K., Pálfy M., Coates J.A. Preprinting a pandemic: the role of preprints in the COVID-19 pandemic. bioRxiv. 2020 doi: 10.1101/2020.05.22.111294. - DOI
    1. Horbach S.P.J.M. Pandemic publishing: Medical journals strongly speed up their publication process for COVID-19. Quantitative Science Studies. 2020;1:1056–1067.
    1. Sachs J.D., Horton R., Bagenal J., Ben Amor Y., Karadag Caman O., Lafortune G. The Lancet COVID-19 Commission. Lancet. 2020;396:454–455. - PMC - PubMed

Publication types

MeSH terms

Associated data